Stanley Capital Management’s QuidelOrtho QDEL Stock Holding History

Stanley Capital Management’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-252,000	Closed	-$4.14M	–	43
2026 Q1	$4.14M	Sell	252,000 -150,000	-37%	-$3.68M	0.69%	40
2025 Q4	$11.5M	Buy	402,000 +25,000	+7%	+$677K	1.92%	24
2025 Q3	$11.1M	Hold	377,000	–	–	1.83%	25
2025 Q2	$10.9M	Buy	377,000 +32,000	+9%	+$946K	1.83%	25
2025 Q1	$12.1M	Buy	345,000 +150,000	+77%	+$6.12M	2.37%	21
2024 Q4	$8.69M	Buy	+195,000	New	+$7.98M	1.69%	29

Other funds holding QDEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Stanley Capital Management's QDEL Position: Q2 2026 in Review

Stanley Capital Management sold out of QuidelOrtho (QDEL) in Q2 2026, closing a stake of 252,000 shares — an estimated $4.14M sold.

Stanley Capital Management first reported a position in QDEL in Q4 2024 and held it in 6 quarters. The position peaked at $12.1M in Q1 2025. 246 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.

Stanley Capital Management reported no remaining QuidelOrtho position as of Q2 2026 after selling out during the quarter.
Stanley Capital Management sold 252,000 QuidelOrtho shares in Q2 2026, an estimated $4.14M.
Stanley Capital Management first reported a position in QuidelOrtho in Q4 2024 and held it in 6 quarters.
Stanley Capital Management's QuidelOrtho position peaked at $12.1M in Q1 2025.
246 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.

Based on Stanley Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.